Interaction of alcohol intake and cofactors on the risk of cirrhosis

Liver Int. 2010 Jul;30(6):867-70. doi: 10.1111/j.1478-3231.2010.02261.x. Epub 2010 May 14.

Abstract

Objective: Evaluation of the interaction between alcohol intake and cofactors [hepatitis B virus (HBV), hepatitis C virus (HCV), body mass index] and coffee consumption on the risk of cirrhosis.

Design: Seven hundred and forty-nine consecutive patients with chronic liver disease referring to units for liver or alcohol diseases in Italy during a 6-months period. Teetotalers were excluded. The odds ratios (OR) for cirrhosis were evaluated using chronic hepatitis cases as the control group.

Results: An alcohol intake of more than 3 units/day resulted associated with the likelihood of cirrhosis both in males (OR 4.3; 95% CI=2.5-7.3) and in females (OR 5.7; 95% CI=2.3-14.5). A multiplicative interaction on the risk of cirrhosis between risky alcohol intake and HBsAg or HCV-Ab/HCV-RNA positivity was observed. A reduction of cirrhosis risk was observed in subjects consuming more than 3 alcohol units/day with increasing coffee intake. The OR for the association with cirrhosis decreased from 2.3 (95% CI=1.2-4.4) in subjects drinking 0-2 cups of coffee/day to 1.4 (95% CI=0.6-3.6) in those drinking more than 2 cups/day.

Conclusions: In subjects with an alcohol intake >3 units/day the coexistence of HBV or HCV multiplies the risk of cirrhosis. Coffee represents a modulator of alcoholic cirrhosis risk.

MeSH terms

  • Adult
  • Aged
  • Alcohol Drinking / adverse effects*
  • Body Mass Index
  • Case-Control Studies
  • Coffee / adverse effects
  • Disease Progression
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis B / complications
  • Hepatitis B / diagnosis
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / immunology
  • Hepatitis C / complications
  • Hepatitis C / diagnosis
  • Hepatitis C Antibodies / blood
  • Humans
  • Italy
  • Liver Cirrhosis / etiology*
  • Male
  • Middle Aged
  • Odds Ratio
  • RNA, Viral / blood
  • Risk Assessment
  • Risk Factors

Substances

  • Coffee
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies
  • RNA, Viral